UCB Korea Co., Ltd. clinical trials
A country office of UCB S.A.
The registry lists 3 studies whose lead sponsor is UCB Korea Co., Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 15, 2017.
Registry sponsor names on this page
- UCB Korea Co., Ltd.3 studies
Something wrong with this grouping? Tell us on the UCB S.A. page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All UCB S.A. studies →
- Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset SeizuresCompletedNCT01229735Phase 4
Sponsor listed in the registry: UCB Korea Co., Ltd.
- Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease PatientsCompletedNCT01523301Phase 4
Sponsor listed in the registry: UCB Korea Co., Ltd.
- Pharmacokinetic Properties of Isosorbide-5-mononitrate Under Fasting and Fed Condition in Healthy Male SubjectsCompletedNCT02101710Phase 1
Sponsor listed in the registry: UCB Korea Co., Ltd.